Sempio Foods (007540)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 43,800.00 |
|---|---|
| 52-week range | 39,750.00 – 73,100.00 |
| Return, 1 month / 3 months | −7.6% / +1.9% |
| Return, 1 year / 3 years | −14.1% / −4.5% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 43.0% |
| Worst drawdown (1 year) | -38.7% |
| Average daily value traded | 1,542.45M KRW |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sempio Foods is a Korean food company based in Seoul that makes traditional condiments and seasonings. Its main products are soy sauce, soybean paste, red chili paste and other fermented sauces used in Korean cooking, along with a range of prepared and processed foods. The company sells to household shoppers through grocery stores and to foodservice and industrial customers, and its products are staples in Korean kitchens and are also exported to overseas markets.
Sempio Foods trades under the code 007540 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sempio Foods (007540) trades on the Korea Stock Exchange in Korea. It last closed at KRW 43,800.00 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 327 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.1% and over the last three months it rose 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.2% | ||
| From 52-week high | -32.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.9% | ||
| 6-month return | -16.7% | ||
| 12-month return, skipping the last month | -7.0% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 43.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.7% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,542.45M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −7.6% |
| 3 months | +1.9% |
| 6 months | −16.7% |
| 1 year | −14.1% |
| 3 years | −4.5% |
| 5 years | −1.7% |
Signals
| 50-day / 200-day average | 45,982.00 / 48,214.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,674.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 200.0000 |
| 27 Dec 2024 | KRW 200.0000 |
| 27 Dec 2023 | KRW 200.0000 |
| 28 Dec 2022 | KRW 200.0000 |
| 29 Dec 2021 | KRW 200.0000 |
| 29 Dec 2020 | KRW 200.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.